Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongcheng Zhu

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
International Journal of Clinical and Experimental Pathology|October 15, 2015
Bortezomib enhances the radiosensitivity of hypoxic cervical cancer cells by inhibiting HIF-1α expressionHeqing Cui, Qin Qin, Meilin Yang, et al.
Scientific Reports|September 29, 2015
Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxiaHongcheng Zhu, Xi Yang, Yuqiong Ding, et al.
Tumori|March 21, 2015
Long-term clinical outcome of intensity-modulated radiation therapy for locally advanced esophageal squamous cell carcinomaXiaolin Ge, Xi Yang, Xiaohu Lu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 3, 2024
Optimizing Crystal Orientation and Defect Mitigation in Antimony Selenide Thin-Film Solar Cells through Buffer Layer Energy Band AdjustmentYusheng Yang, Tingyu Zhang, Hongcheng Zhu, et al.
Clinical and Translational Radiation Oncology|January 14, 2026
Postoperative chemoradiotherapy for esophageal squamous cell Carcinoma: Results from ESO-Shanghai 17 and joint analyses for phase II clinical trialsJingyi Shen, Dashan Ai, Yun Chen, et al.
Oncology Research and Treatment|December 6, 2022
Career and Professional Development for Young OncologistsMaximilian J Mair, Claudia Cardone, Liz Connolly, et al.
Frontiers in Oncology|November 19, 2021
Cancer of Pharyngoesophageal Junction: A Different Subtype From Hypopharyngeal and Cervical Esophageal Cancer?Xiaoyu Li, Dashan Ai, Yun Chen, et al.
Annals of Translational Medicine|October 21, 2022
CBX4 contributes to radioresistance by regulating autophagic activity in esophageal squamous cell carcinomaHongcheng Zhu, Hui Chen, Guangzong Chen, et al.
Eclinicalmedicine|February 15, 2024
Induction sintilimab and chemotherapy followed by concurrent chemoradiotherapy for locally advanced esophageal cancer: a proof-of-concept, single-arm, multicenter, phase 2 trialDashan Ai, Shengnan Hao, Wenbin Shen, et al.
The Lancet. Gastroenterology & Hepatology|November 19, 2023
Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trialQi Liu, Junqiang Chen, Yu Lin, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
International Journal of Clinical and Experimental Pathology|October 15, 2015
Bortezomib enhances the radiosensitivity of hypoxic cervical cancer cells by inhibiting HIF-1α expressionHeqing Cui, Qin Qin, Meilin Yang, et al.
Scientific Reports|September 29, 2015
Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxiaHongcheng Zhu, Xi Yang, Yuqiong Ding, et al.
Tumori|March 21, 2015
Long-term clinical outcome of intensity-modulated radiation therapy for locally advanced esophageal squamous cell carcinomaXiaolin Ge, Xi Yang, Xiaohu Lu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 3, 2024
Optimizing Crystal Orientation and Defect Mitigation in Antimony Selenide Thin-Film Solar Cells through Buffer Layer Energy Band AdjustmentYusheng Yang, Tingyu Zhang, Hongcheng Zhu, et al.
Clinical and Translational Radiation Oncology|January 14, 2026
Postoperative chemoradiotherapy for esophageal squamous cell Carcinoma: Results from ESO-Shanghai 17 and joint analyses for phase II clinical trialsJingyi Shen, Dashan Ai, Yun Chen, et al.
Oncology Research and Treatment|December 6, 2022
Career and Professional Development for Young OncologistsMaximilian J Mair, Claudia Cardone, Liz Connolly, et al.
Frontiers in Oncology|November 19, 2021
Cancer of Pharyngoesophageal Junction: A Different Subtype From Hypopharyngeal and Cervical Esophageal Cancer?Xiaoyu Li, Dashan Ai, Yun Chen, et al.
Annals of Translational Medicine|October 21, 2022
CBX4 contributes to radioresistance by regulating autophagic activity in esophageal squamous cell carcinomaHongcheng Zhu, Hui Chen, Guangzong Chen, et al.
Eclinicalmedicine|February 15, 2024
Induction sintilimab and chemotherapy followed by concurrent chemoradiotherapy for locally advanced esophageal cancer: a proof-of-concept, single-arm, multicenter, phase 2 trialDashan Ai, Shengnan Hao, Wenbin Shen, et al.
The Lancet. Gastroenterology & Hepatology|November 19, 2023
Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trialQi Liu, Junqiang Chen, Yu Lin, et al.
Pageof 9